Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1990 1
1992 3
1993 1
1995 3
1996 1
1997 1
1998 4
1999 2
2000 2
2001 1
2002 1
2003 2
2004 2
2005 1
2006 3
2007 2
2008 5
2009 3
2010 1
2011 7
2012 6
2013 6
2014 8
2015 11
2016 4
2017 9
2018 10
2019 10
2020 14
2021 14
2022 3
2023 10
2024 13
2025 11
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U, Herhaus P, Benedetti F, Sonnevi K, Hanoun C, Hänel M, Dierlamm J, Pott C, Klapper W, Gözel D, Schmidt C, Unterhalt M, Ladetto M, Hoster E. Dreyling M, et al. Among authors: celli m. Lancet. 2024 May 25;403(10441):2293-2306. doi: 10.1016/S0140-6736(24)00184-3. Epub 2024 May 2. Lancet. 2024. PMID: 38705160 Free article. Clinical Trial.
Specifications and validation of the ACMG/AMP criteria for clinical interpretation of sequence variants in collagen genes associated with joint hypermobility.
Leone MP, Morlino S, Nardella G, Pracella R, Giachino D, Celli L, Baldo D, Turolla L, Piccione M, Salzano E, Busè M, Lastella P, Zollino M, Cantone R, Grosso E, Zonta A, Pasini B, Piscopo C, De Maggio I, Priolo M, Mammi C, Foiadelli T, Trabatti C, Savasta S, Iolascon A, Ferraris A, Lodato V, Di Giosaffatte N, Majore S, Selicorni A, Petracca A, Fusco C, Celli M, Guarnieri V, Micale L, Castori M. Leone MP, et al. Among authors: celli m. Hum Genet. 2023 Jun;142(6):785-808. doi: 10.1007/s00439-023-02547-z. Epub 2023 Apr 20. Hum Genet. 2023. PMID: 37079061
Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients.
Maioli M, Gnoli M, Boarini M, Tremosini M, Zambrano A, Pedrini E, Mordenti M, Corsini S, D'Eufemia P, Versacci P, Celli M, Sangiorgi L. Maioli M, et al. Among authors: celli m. Eur J Hum Genet. 2019 Jul;27(7):1090-1100. doi: 10.1038/s41431-019-0373-x. Epub 2019 Mar 18. Eur J Hum Genet. 2019. PMID: 30886339 Free PMC article. Clinical Trial.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Conconi A, Chiappella A, Ferreri AJM, Stathis A, Botto B, Sassone M, Gaidano G, Balzarotti M, Merli F, Tucci A, Vanazzi A, Tani M, Bruna R, Orsucci L, Cabras MG, Celli M, Annibali O, Liberati AM, Zanni M, Ghiggi C, Pisani F, Pinotti G, Dore F, Esposito F, Pirosa MC, Cesaretti M, Bonomini L, Vitolo U, Zucca E. Conconi A, et al. Among authors: celli m. Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251. Blood Adv. 2024. PMID: 38181782 Free PMC article. Clinical Trial.
Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis Imperfecta.
Celli L, Garrelfs MR, Sakkers RJB, Elting MW, Celli M, Bökenkamp A, Smits C, Goderie T, Smit JM, Schwarte LA, Schober PR, Lubbers WD, Visser MC, Kievit AJ, van Royen BJ, Gilijamse M, Schreuder WH, Rustemeyer T, Pramana A, Hendrickx JJ, Dahele MR, Saeed P, Moll AC, Curro-Tafili KR, Ghyczy EAE, Dickhoff C, de Leeuw RA, Bonjer JH, Nieuwenhuijzen JA, Konings TC, Engelsman AF, Eeckhout AM, van den Aardweg JG, Thoral PJ, Noske DP, Dubois L, Teunissen BP, Semler O, Wekre LL, Maasalu K, Märtson A, Sangiorgi L, Versacci P, Riminucci M, Grammatico P, Zambrano A, Martini L, Castori M, Botman E, Westerheim I, Zhytnik L, Micha D, Eekhoff EMW. Celli L, et al. Among authors: celli m. Calcif Tissue Int. 2024 Dec;115(6):960-975. doi: 10.1007/s00223-024-01305-1. Epub 2024 Nov 13. Calcif Tissue Int. 2024. PMID: 39535563 Free PMC article.
Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice.
Frustaci AM, Galitzia A, Lucignano M, Appio L, Olivieri J, Sanna A, Baraté C, Pane F, Schiattone L, Casadei B, Ferrarini I, Figuera A, Sportoletti P, Loseto G, Stelitano C, Visentin A, Celli M, Mauro FR, Palombi M, Coscia M, Innao V, Moia R, Motta M, Russo F, Tani M, Arcari A, Boccellato E, Borella C, Capochiani E, Ferrari A, Gentile M, Giachetti R, Giordano A, Bullo M, Lista E, Malandruccolo L, Musso M, Varettoni M, Vozella F, Cibien F, Merli M, Nocilli L, Pasquini MC, Romeo AA, Rossi V, Turri G, Vanazzi A, Cavaliere M, Gozzetti A, Crucitti L, Lucesole M, Deodato M, Tomasso A, Zappaterra A, Murru R, Patti C, Laurenti L, Tedeschi A. Frustaci AM, et al. Among authors: celli m. Haematologica. 2026 Jan 1;111(1):206-218. doi: 10.3324/haematol.2025.287799. Epub 2025 Jun 26. Haematologica. 2026. PMID: 40568727 Free PMC article.
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.
Marini I, Giunta EF, Nicolini S, Grassi I, Foca F, Sarnelli A, Di Iorio V, Vizza L, Giani E, Celli M, Monti M, Severi S, De Giorgi U, Borgia F, Paganelli G, Matteucci F, Sansovini M. Marini I, et al. Among authors: celli m. Eur J Nucl Med Mol Imaging. 2026 Apr;53(5):3023-3033. doi: 10.1007/s00259-025-07661-w. Epub 2025 Nov 27. Eur J Nucl Med Mol Imaging. 2026. PMID: 41307700 Free PMC article. Clinical Trial.
PSMA for HCC: a new frontier in precision medicine for liver cancer?
Caroli P, Rossetti V, Sansovini M, Fantini L, Marini I, Nicolini S, Grassi I, Matteucci F, Di Iorio V, Celli M. Caroli P, et al. Among authors: celli m. Cancer Treat Res Commun. 2026;47:101169. doi: 10.1016/j.ctarc.2026.101169. Epub 2026 Mar 5. Cancer Treat Res Commun. 2026. PMID: 41831332 Free article. Review.
A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.
Gugliotta G, Argnani L, Cantelli M, Pinto A, Gorgone A, Piazza F, Fozza C, Fesce VF, Marino F, Celli M, Pennese E, Gaudio F, Lauzzana P, Pezzullo L, Lorenzo S, Nierychlewska PM, Ceparano G, Pane F, Casadei B, Pellegrini C, Romano C, Zinzani PL. Gugliotta G, et al. Among authors: celli m. Am J Hematol. 2026 Jul;101(7):1527-1537. doi: 10.1002/ajh.70317. Epub 2026 Apr 10. Am J Hematol. 2026. PMID: 41960655
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.
Rizzello I, Sacchetti I, Barbato S, Solli V, Stefanoni P, Cani L, Quaresima M, Belotti A, Sgherza N, Gentile M, Zambello R, Barilà G, Celli M, Mele G, Mancuso K, Pantani L, Tacchetti P, Talarico M, Puppi M, Manzato E, Restuccia R, Masci S, Ghibellini S, Bigi F, Cavo M, Zamagni E. Rizzello I, et al. Among authors: celli m. Clin Exp Med. 2025 Nov 25;26(1):43. doi: 10.1007/s10238-025-01956-w. Clin Exp Med. 2025. PMID: 41286382 Free PMC article.
170 results